Cerus Inc (CERS): Market Capitalization-to-Revenue Ratio

Symbol and logo of brand Cerus Corp (CERS)

Cerus Corporation is striving for global dominance by expanding the implementation of the INTERCEPT system across blood transfusion centers. The revenue valuation metric on the GURU.Markets chart reflects a trend where the value of 1.80 serves as the target level. Its monopolist status allows the company to exercise pricing power over consumables, while the large-scale robotization of pathogen inactivation processes minimizes human error.

Price-to-Revenue Ratio: Cerus (CERS) for 07/04/2022 - 11/15/2026

Metric breakdowns and analytics for Cerus (CERS)

- stock quotes and analyst forecast:
Summary company analytics:Cerus Corp.
Mass-produced product of cerus.com

To identify fundamental leaders, analysts utilize the P/S ratio, which relates market capitalization to annual revenue to measure the premium the market is willing to pay per unit of sales. In the case of Cerus Corporation (CERS), this price-to-sales valuation reflects confidence in management's expansion strategy within the blood safety niche and their ability to monetize regulatory approvals.

Competitors of Cerus Corporation

Market Cap to Sales Volume ISRG|Danaher Corporation - Market Cap to Revenue|P/S Multiple Becton Dickinson & Company BDX|STE - Price-to-Revenue Ratio|West Pharmaceutical Services (WST) - Market Cap to Revenue|BAX: P/S Multiple|Market Cap to Revenue Masimo|STVN (stevanatogroup.com) - P/S Multiple|Market Cap to Revenue Ratio TFX (Teleflex Incorporated)|Price-to-Revenue Ratio Merit Medical (MMSI)|Envista - Market Cap to Revenue Ratio|ICU Medical, Inc. - Market Cap to Revenue|Market Cap to Sales Volume XRAY (Dentsply Sirona Inc)|LMAT - Price-to-Revenue Ratio|Price-to-Revenue Coefficient AtriCure Corp ATRC|staar.com (STAA) - Price-to-Revenue Ratio|Market Cap to Revenue ChromaDex Corporation|ZIMV (ZimVie Inc) - P/S Multiple|Market Cap to Revenue Ratio ANGO (AngioDynamics)|Price-to-Revenue Ratio Teknova (TKNO)|Monogram Orthopedics Inc. - Market Cap to Revenue Ratio|Price-to-Revenue Ratio Sharps Technology, Inc. STSS|P/S Multiple InfuSystem Holdings INFU|UTMD: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio KRMD (KORU Medical)|NYXH: P/S Multiple|MBOT (Microbot Medical, Inc) - Price-to-Revenue Ratio|Market Cap to Revenue PDEX|ZTEK: Market Capitalization-to-Revenue Ratio|P/S Multiple ELUT|Milestone Scientific Inc. - Market Cap to Revenue Ratio|Price-to-Revenue Ratio NEXGEL, Inc. NXGL|Retractable Tech - Price-to-Revenue Ratio|harvardbioscience.com - P/S Multiple|FEMY (Femasys Inc.) - Market Cap to Revenue Ratio|MHUA: P/S Multiple|Predictive Oncology Corp - Market Capitalization-to-Revenue Ratio|CJMB (Callan JMB) - P/S Multiple|Price to Sales Atrion Corporation Inc. ATRI|P/S Multiple NURO